Lorenzo Montanaro Selected Research

Lorenzo Montanaro Research Topics

Disease

26	Neoplasms (Cancer) 10/2020 - 12/2002
7	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2008
2	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 07/2010 - 06/2010
1	Bone Marrow Failure Disorders 01/2020
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2020
1	Cockayne Syndrome (Syndrome, Cockayne) 01/2018
1	Inflammation (Inflammations) 09/2016
1	Lung Neoplasms (Lung Cancer) 08/2015
1	Cholangiocarcinoma 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 10/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2013
1	Prostatic Neoplasms (Prostate Cancer) 07/2013
1	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Triple Negative Breast Neoplasms 01/2013
1	Colonic Neoplasms (Colon Cancer) 01/2013
1	Retinoblastoma (Glioblastoma, Retinal) 04/2008
1	Hepatocellular Carcinoma (Hepatoma) 02/2005
1	Carcinogenesis 11/2004
1	Neuroblastoma 02/2004
1	Carcinoma (Carcinomatosis) 12/2002

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2002
3	RNA Polymerase I (Polymerase I, RNA)IBA 01/2018 - 09/2011
3	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2010 - 01/2008
2	Messenger RNA (mRNA)IBA 10/2020 - 01/2013
2	Small Nucleolar RNA (snoRNA)IBA 01/2020 - 07/2013
2	Ribosomal RNAIBA 12/2016 - 02/2005
2	telomerase RNA (bTR)IBA 08/2015 - 01/2008
2	Ribosomal DNA (rDNA)IBA 03/2015 - 05/2014
2	Internal Ribosome Entry SitesIBA 09/2013 - 06/2010
2	Small Interfering RNA (siRNA)IBA 09/2011 - 06/2010
2	Fluorouracil (Carac)FDA LinkGeneric 11/2009 - 04/2008
2	Methotrexate (Mexate)FDA LinkGeneric 11/2009 - 04/2008
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 08/2008 - 04/2008
2	Eukaryotic Initiation Factor-4EIBA 11/2004 - 05/2004
1	Biological ProductsIBA 10/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2016
1	CytokinesIBA 09/2016
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Proanthocyanidins (Procyanidins)IBA 10/2014
1	Nonesterified Fatty Acids (NEFA)IBA 10/2014
1	Eicosapentaenoic AcidIBA 10/2014
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 10/2014
1	28S Ribosomal RNAIBA 07/2013
1	ST1326IBA 04/2013
1	Antineoplastic Agents (Antineoplastics)IBA 04/2013
1	AcyltransferasesIBA 04/2013
1	Carnitine (L-Carnitine)FDA LinkGeneric 04/2013
1	ELAV-Like Protein 1IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	beta CateninIBA 01/2013
1	E2F1 Transcription FactorIBA 09/2011
1	pseudouridine synthasesIBA 07/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2009
1	Cytostatic AgentsIBA 11/2009
1	Retinoblastoma ProteinIBA 11/2009
1	AntimetabolitesIBA 04/2008
1	Complement System Proteins (Complement)IBA 02/2005
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2004
1	Peptide Nucleic AcidsIBA 02/2004
1	SilverIBA 12/2002
1	Thymidylate SynthaseIBA 12/2002

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2019 - 04/2008
2	Adjuvant Chemotherapy 11/2009 - 04/2008
2	Therapeutics 04/2008 - 11/2004